Transcatheter Aortic Valve Replacement Clinical Trial
Official title:
Coronary ANgiography and ACCESS Following Implantation of a Supra-Annular Transcatheter Heart Valve With Commissural Alignment: The CAN-ACCESS Pilot Study
To determine the optimal technique and equipment for selective coronary engagement specifically following Evolut THV implantation using commissural alignment.
Patients will undergo elective transfemoral TAVR with the Evolut THV. The operators will attempt to selectively engage both the right and left coronary arteries through standardized angiographic views. The CCI-CIC CoreLabs will adjudicate angiographic views, post-TAVR CT scan, and determine if the coronaries were selectively engaged. Catheter choice, adjunctive tools if needed (e.g guide extension, wires etc) and engagement technique will be at the discretion of the operator. All images and fluoroscopic views will be anonymized, saved and imported to the CCI-CIC Angiographic and CT CoreLabs. Statistical analysis: Patient baseline and outcome data will be presented as mean and standard deviation (SD) for normally distributed variables, median and interquartile range (IQR) for non-normally distributed variables, and frequency and proportion for categorical variables. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05465655 -
Cara CDRM (Conduction Disturbance Risk Monitor) 2.0
|
N/A | |
Recruiting |
NCT04870424 -
Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement
|
Phase 3 | |
Completed |
NCT02758964 -
Evaluation of Cerebral Thrombembolism After TAVR
|
||
Recruiting |
NCT05758701 -
CT TAVR Abdomen Study
|
Phase 4 | |
Active, not recruiting |
NCT04281771 -
Assessment of Paravalvular Leak After TAVI by Hemodynamic Measurements and Cardiac MRI
|
N/A | |
Enrolling by invitation |
NCT06212050 -
Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis
|
||
Recruiting |
NCT04573049 -
The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve Replacement
|
Phase 4 | |
Recruiting |
NCT05235555 -
EffecTAVI Registry
|
||
Completed |
NCT05082337 -
The SAVVY Guidewire in Transcatheter Aortic Valve Replacement Procedures
|
N/A | |
Completed |
NCT01627691 -
REPRISE II: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve System
|
N/A | |
Completed |
NCT01651780 -
Open-label, Randomized Trial in Patients Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH
|
Phase 3 | |
Recruiting |
NCT05259241 -
ADAPT Transcatheter Aortic Valve Intervention (TAVI & Chronic Total Occlusion Percutaneous Coronary Intervention (CTO PCI)
|
N/A | |
Completed |
NCT04489914 -
Observational Study on the Application of High-Flow Therapy After Percutaneous Transfemoral Aortic Valve Replacement
|
||
Recruiting |
NCT03649594 -
Risk Stratification Post TAVI Using TEG
|
||
Completed |
NCT04659538 -
The CAPTIS® Study - Embolic Protection in TAVR
|
N/A | |
Recruiting |
NCT04107038 -
Monitored Anesthesia Care vs. General Anesthesia for Transcatheter Aortic Valve Replacement
|
N/A | |
Withdrawn |
NCT04268160 -
GPx Activity in Subjects With Aortic Stenosis Undergoing TAVR
|
||
Recruiting |
NCT02812953 -
Biological Collection and Registry of Patients Who Will Have a TAVR (Transcatheter Aortic Valve Replacement) Intervention
|
||
Recruiting |
NCT05217888 -
The Sentinel Registry
|
||
Recruiting |
NCT04982406 -
Transcatheter Aortic Valve Replacement (TAVR) Effects on Cardiac Conduction System
|